2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Lymph Node Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Downes, M; Gudas, LJ; Kauffman, EC; Marcinkiewicz, K; Mongan, NP; Robinson, BD; Scherr, DS; Vourganti, S | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Lymph Node Metastasis
Article | Year |
---|---|
Estrogen receptor-β expression and pharmacological targeting in bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Cystectomy; Disease-Free Survival; Estrogen Receptor beta; Estrogens; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Propionates; Signal Transduction; Survival; Tamoxifen; Urinary Bladder Neoplasms; Urothelium | 2013 |